Charles River Laboratories announces extended relationship with The Michael J. Fox Foundation
Extension includes new project to phenotype Parkinson’s disease models and the continuation of LRRK2 research.
List view / Grid view
Extension includes new project to phenotype Parkinson’s disease models and the continuation of LRRK2 research.
Researchers have discovered that a signalling protein elevated in patients with AML plays a much wider role in the disease than previously thought...
In a new study based on mouse cells, researchers have identified several new potential targets using state-of-the-art technology, many of which could be employed for future treatment of different types of cancers and diseases.
Researchers have identified a protein critical for the aggressiveness of T-cell leukaemia...
A study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of aggressive ALS...
A compound may be effective against other autoimmune diseases, mouse study shows...
Researchers have uncovered a new protein shield that aids in repairing damaged DNA in cells and affects resistance to drugs used for breast cancer treatment...
There are no short-cuts in the complex field of lipidomics, explains Cristina Legido-Quigley, a Principal Investigator in Systems Medicine at Steno Diabetes Center Copenhagen in Denmark and at King’s College London.
Researchers at the Medical University of South Carolina (MUSC) have identified a novel checkpoint of peripheral tolerance, specifically in B cells.
Chemotherapy-induced hemorrhagic cystitis alleviated by a protein that parasites use to keep hosts alive...
NIH scientists discover macromolecular complexes that could enable medication development...
Researchers have uncovered new answers about why cells rapidly age in children with the rare and fatal disease, Hutchinson-Gilford Progeria Syndrome (HGPS).
Study overturns previous ideas about enzyme linked to many illnesses
A study has pinpointed a molecule that links autophagy and apoptosis, namely a transcription factor called FOXO3a.
A discovery sheds light on how cancerous cells differ from healthy ones and could lead to the development of new strategies for therapeutic intervention for difficult-to-treat cancers...